Investing News / Market Commentary
Masimo vs. Apple: A Legal Battle Shaping the Tech Landscape
The recent turmoil surrounding Masimo (MASI) following a U.S. appeals court’s decision to temporarily pause ...
Read MoreInvesting News / Market Commentary
The recent turmoil surrounding Masimo (MASI) following a U.S. appeals court’s decision to temporarily pause ...
Read MoreInvesting News / Market Commentary
Iovance Biotherapeutics (IOVA) finds itself at a critical crossroads following a setback that led to ...
Read MoreInvesting News / Market Commentary
The skies have grown turbulent for Spirit Airlines (SAVE) this week, as the planned $3.8 ...
Read MoreInvesting News / Market Commentary
In the ever-evolving world of cryptocurrencies, Ripple (XRP) CEO Brad Garlinghouse has thrown verbal jabs ...
Read MoreInvesting News / Market Commentary
GoodRx, the telemedicine platform synonymous with affordable drug discounts, finds itself at an interesting crossroads ...
Read MoreInvesting News / Market Commentary
EchoStar (SATS), the parent company of Dish Network, finds itself in a complex dance with ...
Read MoreInvesting News / Market Commentary
Coherent (COHR) is making waves in the tech world, and growth investors are taking notice ...
Read MoreInvesting News / Market Commentary / Uncategorized
Bowlero Corporation (BOWL) has been quietly rolling its way through strategic acquisitions, aiming to reshape ...
Read MoreInvesting News / Market Commentary
The legal showdown between OpenAI and the New York Times (NYT) has added yet another ...
Read MoreInvesting News / Market Commentary
Cytokinetics (CYTK) has surged to the forefront of pharmaceutical headlines, capturing the attention of growth ...
Read MoreInvesting News / Market Commentary
Match Group (MTCH), the behemoth behind popular dating platforms such as Match.com, Tinder, and Hinge, ...
Read MoreInvesting News / Market Commentary
Spirit AeroSystems (SPR), a key player in the aerospace manufacturing industry, finds itself navigating through ...
Read MoreInvesting News / Market Commentary
The world of biotechnology and pharmaceuticals witnessed a significant development as Recursion Pharmaceuticals (RXRX) introduced ...
Read MoreGet 30+ hours of analyst research directly in your inbox weekly. Sign-up today to stay on top of the market.